Cargando…
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease (NAFLD) is a growing global phenomenon, and its damaging effects in terms of cardiovascular disease (CVD) risk are becoming more apparent. NAFLD is estimated to affect around one quarter of the world population and is often comorbid with other metabolic disorders inc...
Autores principales: | Josloff, Kevan, Beiriger, Jacob, Khan, Adnan, Gawel, Richard J., Kirby, Richard S., Kendrick, Aaron D., Rao, Abhinav K., Wang, Roy X., Schafer, Michelle M., Pearce, Margaret E., Chauhan, Kashyap, Shah, Yash B., Marhefka, Gregary D., Halegoua-DeMarzio, Dina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786069/ https://www.ncbi.nlm.nih.gov/pubmed/36547416 http://dx.doi.org/10.3390/jcdd9120419 |
Ejemplares similares
-
Coronary artery disease and non‐alcoholic fatty liver disease: Clinical correlation using computed tomography coronary calcium scans
por: Kirby, Richard S, et al.
Publicado: (2021) -
Safe Use of POEM in a Patient With Decompensated Cirrhosis and Severe Achalasia
por: Loh, Rebecca, et al.
Publicado: (2023) -
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
por: Xie, Chencheng, et al.
Publicado: (2019) -
Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies
por: Gosalia, Dhaval, et al.
Publicado: (2022) -
Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis
por: Habig, Gregory, et al.
Publicado: (2021)